Bristol-Myers (BMY -0.7%) received a subpoena from the SEC in March in connection with a foreign...

|About: Bristol-Myers Squibb Company (BMY)|By:, SA News Editor

Bristol-Myers (BMY -0.7%) received a subpoena from the SEC in March in connection with a foreign bribery probe. The investigation primarily centers around the company's sales and marketing practices in various countries. BMY says it's fully cooperating with the government.